首页|木丹颗粒联合依帕司他治疗糖尿病周围神经病变的效果

木丹颗粒联合依帕司他治疗糖尿病周围神经病变的效果

扫码查看
目的 探讨木丹颗粒联合依帕司他治疗糖尿病周围神经病变(DPN)的效果。方法 选取2018 年1月至12月收治的 96 例DPN患者作为研究对象,按照随机数字表法将其分为对照组和观察组,各 48 例。两组均行调控血糖及营养神经治疗,对照组给予依帕司他治疗,观察组在对照组基础上加用木丹颗粒。比较两组的治疗效果。结果 治疗后,两组的密西根神经病变筛查量表(MNSI)评分均低于治疗前,且观察组低于对照组,差异具有统计学意义(P<0。05)。治疗后,两组的腓总神经、正中神经感觉神经传导速度(SCV)和运动神经传导速度(MCV)均高于治疗前,差异具有统计学意义(P<0。05);治疗后,观察组的腓总神经、正中神经SCV高于对照组,差异具有统计学意义(P<0。05)。观察组的治疗总有效率高于对照组,差异具有统计学意义(P<0。05)。治疗过程中未观察到胃肠道不适、药物过敏等症状。结论 木丹颗粒联合依帕司他治疗DPN的效果较好,且安全性高,值得临床推广。
Effect of Mudan granule combined with epalrestat in the treatment of diabetic peripheral neuropathy
Objective To investigate the effect of Mudan granule combined with epalrestat in the treatment of diabetic peripheral neuropathy(DPN).Methods A total of 96 patients with DPN admitted from January to December 2018 were selected as the research objects and divided into control group and observation group according to the random number table method,with 48 cases in each group.Both groups were treated with blood glucose regulation and neurotrophic therapy,the control group was treated with epalrestat,and the observation group was treated with Mudan granule on the basis of the control group.The therapeutic effects of the two groups were compared.Results After treatment,the score of Michigan Neuropathy Screening Instrument(MNSI)in the two groups was lower than that before treatment,and that in the observation group was lower than the control group,and the difference was statistically significant(P<0.05).After treatment,the sensory nerve conduction velocity(SCV)and motor nerve conduction velocity(MCV)of common peroneal nerve and median nerve in the two groups were higher than those before treatment,and the differences were statistically significant(P<0.05);after treatment,the SCV of common peroneal nerve and median nerve in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).No gastrointestinal discomfort,drug allergy and other symptoms were observed during the treatment.Conclusion Mudan granule combined with epalrestat in the treatment of DPN has a better effect,and with high safety,it is worthy of clinical promotion.

Mudan granuleepalrestatdiabetic peripheral neuropathy

王晓芳、郑少华、刘利宁

展开 >

西安医学院第二附属医院神经内科,陕西 西安,710038

西安交通大学第一附属医院麻醉科,陕西 西安,710061

木丹颗粒 依帕司他 糖尿病周围神经病变

陕西省重点研发计划

S2021-YF-YBSF-0301

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(3)
  • 20